These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30883602)

  • 41. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial.
    Dusser D; Wise RA; Dahl R; Anzueto A; Carter K; Fowler A; Calverley PM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():133-45. PubMed ID: 26855568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploration of the feasibility to combine patients with chronic obstructive pulmonary disease and chronic heart failure in self-management groups with focus on exercise self-efficacy.
    Giezeman M; Theander K; Zakrisson AB; Sundh J; Hasselgren M
    Scand J Prim Health Care; 2022 Jun; 40(2):208-216. PubMed ID: 35575429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute values of lung function explain the sex difference in breathlessness in the general population.
    Ekström M; Schiöler L; Grønseth R; Johannessen A; Svanes C; Leynaert B; Jarvis D; Gislason T; Demoly P; Probst-Hensch N; Pin I; Corsico AG; Forsberg B; Heinrich J; Nowak D; Raherison-Semjen C; Dharmage SC; Trucco G; Urrutia I; Martinez-Moratalla Rovira J; Sánchez-Ramos JL; Janson C; Torén K
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28546280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Socioeconomic circumstances and incidence of chronic obstructive pulmonary disease (COPD) in an urban population in Sweden.
    Borné Y; Ashraf W; Zaigham S; Frantz S
    COPD; 2019 Feb; 16(1):51-57. PubMed ID: 30917705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of Chronic Obstructive Pulmonary Disease to Cardiovascular Disease in the General Population.
    Song S; Yang PS; Kim TH; Uhm JS; Pak HN; Lee MH; Joung B
    Am J Cardiol; 2017 Oct; 120(8):1399-1404. PubMed ID: 28826898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daily physical activity and related risk factors in COPD.
    Albarrati AM; Gale NS; Munnery MM; Cockcroft JR; Shale DJ
    BMC Pulm Med; 2020 Mar; 20(1):60. PubMed ID: 32138714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
    Hawkins NM; Nordon C; Rhodes K; Talukdar M; McMullen S; Ekwaru P; Pham T; Randhawa AK; Sin DD
    Heart; 2024 Apr; 110(10):702-709. PubMed ID: 38182279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Causes of deaths in COPD patients in primary care setting--a 6-year follow-up.
    Pływaczewski R; Maciejewski J; Bednarek M; Zieliński J; Górecka D; Śliwiński P
    Pneumonol Alergol Pol; 2015; 83(3):193-202. PubMed ID: 26050979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.
    Söderholm M; Inghammar M; Hedblad B; Egesten A; Engström G
    Eur J Epidemiol; 2016 Feb; 31(2):159-68. PubMed ID: 26711630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The relevance of the 6 minutes walking test and of dyspnea measured with mMRC scale in evaluating COPD severity].
    Mănescu V
    Pneumologia; 2012; 61(3):153-9. PubMed ID: 23173376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study.
    Yorke J; Khan N; Garrow A; Tyson S; Singh D; Vestbo J; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2289-2299. PubMed ID: 36133735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and severity of differing dimensions of breathlessness among elderly males in the population.
    Olsson M; Currow DC; Johnson MJ; Sandberg J; Engström G; Ekström M
    ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35141316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
    Nishimura K; Oga T; Tsukino M; Hajiro T; Ikeda A; Jones PW
    Respir Investig; 2014 Mar; 52(2):129-35. PubMed ID: 24636269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.
    Price DB; Baker CL; Zou KH; Higgins VS; Bailey JT; Pike JS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():551-61. PubMed ID: 24920893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.